Corrigendum: Nitazoxanide, an antiprotozoal drug, reduces bone loss in ovariectomized mice by inhibition of RANKL-induced osteoclastogenesis

Affiliations

Chang-hong Li: Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, China
Chang-hong Li: Osteoporosis and Bone Metabolic Diseases Center, Peking University Third Hospital, Beijing, China
Zi-rui Lü: Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China
Zhen-da Zhao: Osteoporosis and Bone Metabolic Diseases Center, Peking University Third Hospital, Beijing, China
Zhen-da Zhao: Department of Orthopaedics, Peking University Third Hospital, Beijing, China
Xin-yu Wang: Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, China
Hui-jie Leng: Osteoporosis and Bone Metabolic Diseases Center, Peking University Third Hospital, Beijing, China
Hui-jie Leng: Beijing Key Laboratory of Spinal Disease Research, Beijing, China
Yan Niu: Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China
Mo-pei Wang: Osteoporosis and Bone Metabolic Diseases Center, Peking University Third Hospital, Beijing, China
Mo-pei Wang: Department of Tumor Chemotherapy and Radiation Sickness, Peking University Third Hospital, Beijing, China

Abstract

No abstracts available.